Knowledge Hub · I-131 Therapy
The clinical + regulatory framework around radioactive-iodine therapy.
I-131 therapy sits inside a two-layer framework: the clinical guidelines (ATA, EANM, SNMMI) defining who, when and how much; and the regulatory chain (AERB SC/MED-4, IAEA SRS 63, ICRP Publication 94) defining ward design, waste handling and patient-release criteria. Six anchor documents cover both.
Standards framework
Six documents that shape the therapy programme.
EANM procedure guidelines for therapy with iodine-131 (I-131) (2022)
The European Association of Nuclear Medicine's updated procedure guideline for I-131 therapy — indications for differentiated thyroid cancer ablation, hyperthyroidism, benign nodular disease, activity selection, patient preparation, dosimetry-based vs empiric activity choice.
Open standard →
American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
The ATA management guideline — the definitive reference on when radioactive-iodine therapy is indicated in DTC, activity-selection tiers by risk stratification, and post-ablation whole-body-scan workflow.
Open standard →
SNMMI/EANM Practice Guideline for Post-Therapy Imaging in DTC Patients
Post-therapy planar + SPECT/CT scan workflow after I-131 ablation. Anchors the "why we image day-3 to day-10 post-ablation" answer and defines the imaging QC that closes out an ablation cycle.
Open standard →
Safety Code for Nuclear Medicine Facilities
India's regulatory code for nuclear medicine — includes the therapy-ward design requirements, isolation-room air-change rate, waste-handling for I-131 patient excreta, and the discharge-activity thresholds patients must fall below before release.
Open standard →
Release of Patients After Radionuclide Therapy
The IAEA guide on the calculations, hospital-stay logic, radiation-protection advice to household + travel companions, and hospital-discharge dose-rate thresholds for I-131 therapy patients.
Open standard →
Release of Patients After Therapy with Unsealed Radionuclides
The ICRP framework document behind IAEA SRS 63 — dose constraints for family members and the public, the dose-rate calculation logic feeding the AERB / IAEA release criteria.
Open standard →
Peer-reviewed literature
Three references the therapy team builds SOPs on.
EANM procedure guidelines for therapy with iodine-131
Silberstein EB, Alavi A, Balon HR, et al.
The definitive procedure guideline. Reviewed inside every teaching-hospital curriculum for I-131 therapy in Europe and India.
Read source →
American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Haugen BR, Alexander EK, Bible KC, et al.
The ATA management guideline — the reference for activity-selection tiers by DTC risk stratification.
Read source →
Practical management of radioactive iodine therapy for differentiated thyroid cancer
Van Nostrand D
Practical workflow-oriented review, cited widely in Indian teaching-hospital I-131 curricula.
Read source →
Literature Radar · auto-updated daily
Latest I-131 therapy research
Peer-reviewed papers on I-131 thyroid therapy, auto-updated from Europe PMC + OpenAlex.
No papers in the radar yet for this topic. The daily poller will populate it over time —subscribe to the weekly digest and the first matches reach your inbox on the next Monday morning.